With the second quarter now in the books but not yet reported, the market will be waiting to see whether patient volumes rebound after a tough first quarter that saw large declines on both the inpatient and outpatient side.
Some early numbers are not encouraging from a market point of view, though they are good news to policymakers and economists concerned about keeping health care costs down.
Lost in the announcement of Tenet Healthcare Corp.'s $4.3 billion deal to buy Vanguard Health Systems was a side note from Tenet Chief Financial Officer Daniel Cancelmi that the company is expecting to report second-quarter admissions that will be 3.5% lower than during the same period the previous year.
As a result, Cancelmi added that the company's adjusted earnings before interest, taxes, depreciation and amortization will come in “toward the low end” of its projected range of $325 million to $375 million when it reports results in early August.